Literature DB >> 15681294

Transcriptional Control of COX-2 via C/EBPbeta.

Kenneth K Wu1, Jun-Yang Liou, Katarzyna Cieslik.   

Abstract

Cyclooxygenase-2 (COX-2) is a highly inducible enzyme exerting diverse actions on cell functions, including proliferation, migration, and DNA damage. Enhanced COX-2 expression may be protective, but excessive expression may be harmful, causing inflammation, atheromatous plaque instability, and intimal hyperplasia. COX-2 transcriptional activation by proinflammatory mediators has been extensively characterized. In this review, the role of C/EBP in regulating COX-2 transcription is highlighted. Recent advances in control of COX-2 transcription by aspirin and salicylate and by a cell cycle-dependent endogenous mechanism are described. The recent progress sheds light on the pathophysiological mechanisms of COX-2 and new transcription-based strategy for controlling COX-2 overexpression and COX-2-mediated cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681294     DOI: 10.1161/01.ATV.0000157899.35660.61

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  21 in total

1.  A distal enhancer controls cytokine-dependent human cPLA2α gene expression.

Authors:  Justin S Bickford; Dawn E Beachy; Kimberly J Newsom; Sarah J Barilovits; John-David H Herlihy; Xiaolei Qiu; Jewell N Walters; Ning Li; Harry S Nick
Journal:  J Lipid Res       Date:  2013-04-02       Impact factor: 5.922

Review 2.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

3.  Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression.

Authors:  Christoph F A Vogel; Wen Li; Eric Sciullo; John Newman; Bruce Hammock; J Rachel Reader; Joseph Tuscano; Fumio Matsumura
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

4.  C/EBPbeta regulates body composition, energy balance-related hormones and tumor growth.

Authors:  Jennifer Staiger; Mary J Lueben; David Berrigan; Radek Malik; Susan N Perkins; Stephen D Hursting; Peter F Johnson
Journal:  Carcinogenesis       Date:  2008-12-04       Impact factor: 4.944

Review 5.  RNAi-based strategies for cyclooxygenase-2 inhibition in cancer.

Authors:  Antonio Strillacci; Cristiana Griffoni; Maria Chiara Valerii; Giorgia Lazzarini; Vittorio Tomasi; Enzo Spisni
Journal:  J Biomed Biotechnol       Date:  2010-06-13

6.  Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells.

Authors:  A Strillacci; C Griffoni; G Lazzarini; M C Valerii; S Di Molfetta; F Rizzello; M Campieri; M P Moyer; V Tomasi; E Spisni
Journal:  Br J Cancer       Date:  2010-08-17       Impact factor: 7.640

7.  Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.

Authors:  Donghong He; Viswanathan Natarajan; Randi Stern; Irina A Gorshkova; Julian Solway; Ernst Wm Spannhake; Yutong Zhao
Journal:  Biochem J       Date:  2008-05-15       Impact factor: 3.857

8.  CCAAT/enhancer binding protein beta is a major mediator of inflammation and viral replication in the gastrointestinal tract of simian immunodeficiency virus-infected rhesus macaques.

Authors:  Mahesh Mohan; Pyone P Aye; Juan T Borda; Xavier Alvarez; Andrew A Lackner
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

9.  Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells.

Authors:  Regina A Oyesanya; Zendra P Lee; Jinhua Wu; Jing Chen; Yuanda Song; Abir Mukherjee; Paul Dent; Tomasz Kordula; Huiping Zhou; Xianjun Fang
Journal:  FASEB J       Date:  2008-03-24       Impact factor: 5.191

10.  Runt-related transcription factor 1 regulates luteinized hormone-induced prostaglandin-endoperoxide synthase 2 expression in rat periovulatory granulosa cells.

Authors:  Jing Liu; Eun-Sil Park; Misung Jo
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.